←Back to Expert Scholars
Translational Medicine / 转化医学HLA Ligandome, Peptide Vaccines
Hans-Georg Rammensee
PhD
🏢University of Tubingen🌐Germany
Professor of Immunology
120
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Hans-Georg Rammensee is a founder of immunopeptidomics and the HLA ligandome, enabling identification of cancer-testis antigen peptides presented on tumor MHC molecules. His peptide vaccine platforms have informed numerous CT-antigen-directed clinical trials.
Share:
🧪Research Fields 研究领域
HLA ligandome
immunopeptidomics
peptide vaccines
MHC epitope discovery
cancer-testis epitopes
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Hans-Georg Rammensee 的研究动态
Follow Hans-Georg Rammensee's research updates
留下邮箱，当我们发布与 Hans-Georg Rammensee（University of Tubingen）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment